Literature DB >> 21744232

MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients.

Milan Hájek1, Monika Dezortová, Dita Wagnerová, Antonín Skoch, Luděk Voska, Irena Hejlová, Pavel Trunečka.   

Abstract

OBJECT: Among several non-invasive methods of liver fat analysis, the most important role is played by MR imaging and spectroscopy (MRS). This study describes the 1H MRS at 3T measurement of liver fat volume fraction Φ(fat) in a group of liver transplant patients, an at-risk group for the development of de novo steatosis.
MATERIALS AND METHODS: Seventy-seven liver transplant recipients who underwent routine protocolar posttransplant examination were divided into three groups: CON-PAT (control group for the cross validation test, 48 patients), PAT-PAT (patients test group for the cross validation test, 29 patients), and PAT (pooled data). Single voxel 1H MRS at 3T was used for the determination of Φ(fat) and histology results (His) were used as the reference standard.
RESULTS: Linear and non-linear regression models were used to describe the relationship between Φ(fat) and His. Strong correlation was found for both models with r = 0.83-0.94 (P < 0.001); a higher r was found for non-linear regression in all tested groups. Areas under receiver operation curves were calculated for cut points His ≥ 5 and > 33% and were found in the range of 0.77-0.86. Fibrosis influences the calculation of Φ(fat) and different slopes were obtained for fibrosis stages F0-F1 and F2-F3, respectively.
CONCLUSION: Significant correlation was found between the results of histology and 1H MRS measurement of liver fat content. The method is suitable for non-invasive repetitive examination of liver fat in liver-transplants patients between protocol biopsies and for the screening of steatosis in other liver diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744232     DOI: 10.1007/s10334-011-0264-9

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  26 in total

1.  Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Michel Petit; Serge Aho; Douraied Ben Salem; David Masson; Patrick Hillon; Jean-Pierre Cercueil; Denis Krause
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

2.  Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content.

Authors:  Jochem R van Werven; Johannes M Hoogduin; Aart J Nederveen; Andre A van Vliet; Ewa Wajs; Petra Vandenberk; Erik S G Stroes; Jaap Stoker
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

Review 3.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

4.  Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.

Authors:  Janus Ong; Zobair M Younossi
Journal:  Am J Gastroenterol       Date:  2010-03       Impact factor: 10.864

5.  Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.

Authors:  Vlad Ratziu; Luminita Bonyhay; Vincent Di Martino; Frederic Charlotte; Lucas Cavallaro; Marie-Hélène Sayegh-Tainturier; Philippe Giral; André Grimaldi; Pierre Opolon; Thierry Poynard
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 7.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

Authors:  Nina F Schwenzer; Fabian Springer; Christina Schraml; Norbert Stefan; Jürgen Machann; Fritz Schick
Journal:  J Hepatol       Date:  2009-06-11       Impact factor: 25.083

8.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

9.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

Authors:  R J Ploeg; A M D'Alessandro; S J Knechtle; M D Stegall; J D Pirsch; R M Hoffmann; T Sasaki; H W Sollinger; F O Belzer; M Kalayoglu
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

10.  Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.

Authors:  Mireen Friedrich-Rust; Cindy Müller; Anne Winckler; Susanne Kriener; Eva Herrmann; Julia Holtmeier; Thierry Poynard; Thomas J Vogl; Stefan Zeuzem; Renate Hammerstingl; Christoph Sarrazin
Journal:  J Clin Gastroenterol       Date:  2010-01       Impact factor: 3.062

View more
  7 in total

1.  The effect of water suppression on the hepatic lipid quantification, as assessed by the LCModel, in a preclinical and clinical scenario.

Authors:  Amandine Coum; Fanny Noury; Elise Bannier; Karima Begriche; Bernard Fromenty; Yves Gandon; Hervé Saint-Jalmes; Giulio Gambarota
Journal:  MAGMA       Date:  2015-11-21       Impact factor: 2.310

2.  In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy.

Authors:  Daniel Keese; Hüdayi Korkusuz; Frank Huebner; Dmitry Namgaladze; Bahram Raschidi; Thomas J Vogl
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

3.  Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study.

Authors:  Jing Qi; Yuman Fong; Leonard Saltz; Michael I D'Angelica; Nancy E Kemeny; Mithat Gonen; Jinru Shia; Amita Shukla-Dave; William R Jarnagin; William M Jarnagin; Richard K G Do; Lawrence H Schwartz; Jason A Koutcher; Kristen L Zakian
Journal:  NMR Biomed       Date:  2012-09-07       Impact factor: 4.044

4.  Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.

Authors:  Stefan Traussnigg; Christian Kienbacher; Martin Gajdošík; Ladislav Valkovič; Emina Halilbasic; Judith Stift; Christian Rechling; Harald Hofer; Petra Steindl-Munda; Peter Ferenci; Fritz Wrba; Siegfried Trattnig; Martin Krššák; Michael Trauner
Journal:  Liver Int       Date:  2017-05-20       Impact factor: 5.828

5.  Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD.

Authors:  Václav Šmíd; Karel Dvořák; Petr Šedivý; Vít Kosek; Martin Leníček; Monika Dezortová; Jana Hajšlová; Milan Hájek; Libor Vítek; Kamila Bechyňská; Radan Brůha
Journal:  Hepatol Commun       Date:  2022-02-11

6.  Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study.

Authors:  Hana Kahleova; Lenka Belinova; Hana Malinska; Olena Oliyarnyk; Jaroslava Trnovska; Vojtech Skop; Ludmila Kazdova; Monika Dezortova; Milan Hajek; Andrea Tura; Martin Hill; Terezie Pelikanova
Journal:  Diabetologia       Date:  2014-05-18       Impact factor: 10.122

7.  Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Jeong Woo Kim; Young-Sun Lee; Yang Shin Park; Baek-Hui Kim; Soo Yeon Lee; Jong Eun Yeon; Chang Hee Lee
Journal:  Sci Rep       Date:  2020-02-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.